Aquestive Therapeutics (NASDAQ:AQST – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by equities research analysts at JMP Securities in a research note issued to investors on Thursday, Benzinga reports. They currently have a $8.00 price objective on the stock. JMP Securities’ price target suggests a potential upside of 403.14% from the stock’s […]
Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (epinephrine) Sublingual Film sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.
Aquestive Therapeutics (AQST) Reaffirms Timeline and Pathway for Anaphylm Sublingual Film streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.